PMID- 29258531 OWN - NLM STAT- MEDLINE DCOM- 20180730 LR - 20181113 IS - 1746-1596 (Electronic) IS - 1746-1596 (Linking) VI - 12 IP - 1 DP - 2017 Dec 19 TI - Malignant rhabdoid tumor in the renal allograft of an adult transplant recipient: a unique case of a rare tumor. PG - 86 LID - 10.1186/s13000-017-0677-5 [doi] LID - 86 AB - BACKGROUND: Renal transplant recipients have increased risk for developing malignant diseases because of immunosuppression or donor-to-recipient transmission. Malignant rhabdoid tumor (MRT) is a rare, highly aggressive and lethal tumor primarily affecting the kidney of infants and young children. MRT has not been reported in the renal allograft of an adult recipient after kidney transplantation. CASE PRESENTATION: In this report, a 47-year-old woman who received a kidney transplantation from an infant donor and developed a mass in the transplanted kidney is presented. Pathological examinations revealed a malignant tumor with rhabdoid cells morphologically and the loss of INI1 expression immunohistochemically. The diagnosis of malignant rhabdoid tumor in the transplanted kidney was made. We confirmed that donor-to-recipient malignancy transmission was the cause of MRT in the transplanted kidney by fluorescence in situ hybridization (FISH) and short tandem repeat (STR) analysis. CONCLUSION: To our knowledge, this is the first case of MRT in an adult renal allograft recipient. This report highlights the importance of the criteria for selection of donors to screen possible malignant tumors transmission. FAU - Xiong, Jing AU - Xiong J AD - Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. FAU - Su, Tiefen AU - Su T AD - Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. AD - Department of Pathology, School of Basic Medical Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China. FAU - Zhu, Pengcheng AU - Zhu P AD - Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. zhupengcheng@hust.edu.cn. AD - Department of Pathology, School of Basic Medical Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China. zhupengcheng@hust.edu.cn. FAU - Ao, Qilin AU - Ao Q AD - Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. AD - Department of Pathology, School of Basic Medical Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China. FAU - Ruan, Qiurong AU - Ruan Q AD - Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. AD - Department of Pathology, School of Basic Medical Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China. FAU - Wang, Guoping AU - Wang G AD - Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. AD - Department of Pathology, School of Basic Medical Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China. LA - eng GR - 81502296/National Natural Science Foundation of China/ PT - Case Reports PT - Journal Article DEP - 20171219 PL - England TA - Diagn Pathol JT - Diagnostic pathology JID - 101251558 SB - IM MH - Allografts/*pathology MH - Female MH - Humans MH - Kidney Neoplasms/*pathology MH - *Kidney Transplantation MH - Middle Aged MH - Rhabdoid Tumor/*pathology MH - Transplant Recipients PMC - PMC5738181 OTO - NOTNLM OT - Donor-to-recipient malignancy transmission OT - Kidney transplantation OT - Malignant rhabdoid tumor (MRT) OT - SMARCB1/INI1 COIS- ETHICS APPROVAL AND CONSENT TO PARTICIPATE: This study was approved by the Ethics committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. CONSENT FOR PUBLICATION: Written informed consent for publication of the clinical details and/or clinical images was obtained from a relative of the patient. A copy of the consent form is available for review by the Editor of this journal. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2017/12/21 06:00 MHDA- 2018/07/31 06:00 PMCR- 2017/12/19 CRDT- 2017/12/21 06:00 PHST- 2017/06/27 00:00 [received] PHST- 2017/12/08 00:00 [accepted] PHST- 2017/12/21 06:00 [entrez] PHST- 2017/12/21 06:00 [pubmed] PHST- 2018/07/31 06:00 [medline] PHST- 2017/12/19 00:00 [pmc-release] AID - 10.1186/s13000-017-0677-5 [pii] AID - 677 [pii] AID - 10.1186/s13000-017-0677-5 [doi] PST - epublish SO - Diagn Pathol. 2017 Dec 19;12(1):86. doi: 10.1186/s13000-017-0677-5.